<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Cambridge Institute for Medical Research</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B9555EF4-3FC8-407F-8EA4-861AC1A5E589"><gtr:id>B9555EF4-3FC8-407F-8EA4-861AC1A5E589</gtr:id><gtr:firstName>Cahir</gtr:firstName><gtr:surname>O'Kane</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/ECC976E7-B6C0-415D-A8FA-FCBF275E7D27"><gtr:id>ECC976E7-B6C0-415D-A8FA-FCBF275E7D27</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Brown</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2313C693-6B5F-4A48-90C5-90D57FC2D64B"><gtr:id>2313C693-6B5F-4A48-90C5-90D57FC2D64B</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>C</gtr:otherNames><gtr:surname>Rubinsztein</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600194"><gtr:id>31187C8B-FECA-4A83-9235-83FE9D81132E</gtr:id><gtr:title>Modifiers of polyglutamine disease pathogenesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600194</gtr:grantReference><gtr:abstractText>Huntington?s disease (HD) is an incurable, disease affecting the brain. It results in abnormal movements, psychiatric disturbances (like depression) and memory problems. HD is a genetic disease and about half of the children of affected individuals are at-risk of developing the disease. A number of studies suggests that there are genetic factors distinct from the primary HD mutation that can modulate the severity of the disease or its age-at-onset. This proposal aims to characterise genetic pathways that reduce the severity of HD in animal models. These genes and pathways will be used to prioritise and eventually select druggable targets for further investigation, e.g. with the aim of developing possible therapies. We will identify such modifiers using mouse and fly models of HD and two complementary genetic approaches that allow us to screen for such modifier genes. The logistics and screening systems for these screens have been established in current MRC grants held by the applicants. We have accumulated a large amount of pilot data that show the likely success of this program. The research will be performed by Prof David Rubinsztein and Dr Cahir O?Kane (University of Cambridge) and Prof Steve Brown (MRC Mammalian Genetics Unit, Harwell).</gtr:abstractText><gtr:technicalSummary>Huntington?s disease (HD) is an incurable, autosomal dominant neurodegenerative disease. It is caused by the abnormal expansion of a CAG trinucleotide repeat close to the N-terminal of the coding part of the gene encoding huntingtin. The CAG repeats encode an expanded polyglutamine (polyQ) repeat tract. About 70% of the variance in the age at onset of HD can be accounted for by CAG repeat number in the disease-causing allele. The residual variance in age at onset unaccounted for by the CAG repeat numbers is likely to be partly due to genetic factors. This proposal aims to characterise genetic pathways that suppress polyglutamine toxicity in vivo. These genes and pathways will be used to prioritise and eventually select druggable targets (e.g. G-protein coupled receptors, ion channels, enzymes and nuclear receptors) for further investigation. We will identify such modifiers using mouse ENU mutagenesis and genome-wide RNAi analysis in fly models integrated with cell biology studies of modifiers. The logistics and screening systems for the mouse ENU program and the RNAi fly screen have been established in current MRC grants held by the applicants. For the ENU program, we have been identifying dominant enhancer or suppressor mutations of the polyQ phenotype by mating hemizygous female transgenic mice expressing the first 171 residues of huntingtin with 82 repeats on a C3HxC57BL/6 background with BALB/c male mice that have been mutagenised with ENU. To date, the screen has been fruitful, yielding 18 phenodeviants - 11 enhancers and 7 suppressors. In the continuation of the program, we aim to identify the causal modifier mutations and continue with restricted further screening focussing on suppressors. For the fly screen, we have developed a moderate-throughput system using polyQ flies expressing the mutant transgene in the eyes. The polyQ fly eyes show loss of pigmentation and necrotic spots. These flies are crossed to RNAi-bearing flies, to give progeny that express both the mutant polyQ allele and the RNAi in the same cells. After optimising the system, we are now screening ~1000 RNAi lines per month. So far we have screened ~2000 crosses, with a suppressor hit rate of ~2.3% and enhancer hit rate of ~9%. For the new program, we aim to complete the genome?wide screen, focussing on supressors. We will select high priority hits from this screen that are conserved in humans, elucidate their functional roles and confirm that they act in the same way in mouse models.</gtr:technicalSummary><gtr:fund><gtr:end>2011-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2727873</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Mitochondrial Biology Unit</gtr:department><gtr:description>Studies of antioxidants as modifiers of Huntington disease</gtr:description><gtr:id>AA0DE7A6-FC2B-4DF5-9B84-3A96615E7DDE</gtr:id><gtr:impact>PubMed ID: 19854266</gtr:impact><gtr:outcomeId>DED283B7E04-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input, novel compounds, testing compounds in normal mice</gtr:partnerContribution><gtr:piContribution>We have done the bulk of the experiments on Huntingtons models, but Dr Murphy has done work on the compounds themselves</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Interview with press</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>55722E2B-D1A0-42D3-AD56-B2FEE0D045BD</gtr:id><gtr:impact>Interviews with journalists at different jounrals

Interest in the field; published articles</gtr:impact><gtr:outcomeId>C8TJU53yvH4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>15 international conferences in 2016 - speaker</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0A0B7E09-1AB7-4830-861E-855BB5F9DF60</gtr:id><gtr:impact>conference presentations at internationa; meetings: Black Forest Winter Conference: &amp;quot;Autophagic Membrane Trafficking &amp;amp; Dynamics in Ageing and Disease&amp;quot; (Freiburg 2016), CHDI's 11th Annual Therapeutics Conference (Palm Springs 2016), International Congress of Human Genetics (Kyoto, 2016), Neuroscience School of Advanced Studies - Autophagy and neuroprotection (Cortona - lecture course 2016), International Society for Developmental Neuroscience (2016, Juan les Pins), European Neuroscience Institute 15th Anniversary Symposium (Gottingen 2016), Keystone Autophagy symposium (Whistler, 2016), Mitochondria: balancing health and disease (London 2016), Nobel conference - The Cell Cycle and Cell Death in Disease (Stockholm, 2016), Centre for Translational Cell Research opening sympiosium (Freiburg 2016), PhD graduate Symposium Cologne Graduate School of Aging Research (2016), Cold Spring Harbor meeting: Neurodegenerative Diseases: Biology &amp;amp; Therapeutics (Cold Spring Harbor 2016), Milner Therapeutics Institute Symposium (Cambridge 2016), 26th Annual Meeting of the Network for European CNS Transplantation &amp;amp; Restoration (NECTAR), Cambridge 2016)</gtr:impact><gtr:outcomeId>5894529ca46787.99751588</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>193442</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Training Fellowship</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Action Medical Research</gtr:fundingOrg><gtr:id>97301CDD-1AA5-450C-8DBE-6E844066A22D</gtr:id><gtr:outcomeId>FTvkeEm1FpY0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6155690</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust/MRC Strategic Award for Neurodegeneration (CONSORTIUM on &amp;quot;Mechanisms of neurotoxicity of amyloid aggregates&amp;quot;)</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>939F812B-844A-4571-A6FF-A6B4B531E86C</gtr:id><gtr:outcomeId>mD1PG65yUZ20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>We found that Rilmenidine an antihypertenisve drug, can induce autophagy and thereby remove mutant huntingtin. This attenuates the severity and delays onset of disease in a mouse model of this disease</gtr:description><gtr:id>4E4D48E8-8B37-42E0-8DBD-27F0DED406BD</gtr:id><gtr:impact>We are planning a safety trial soon in Huntington's idease patients.</gtr:impact><gtr:outcomeId>CVpoCd7Z322</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Therapeutic strategy for Huntington's disease</gtr:title><gtr:type>Preventative Intervention - Nutrition and Chemoprevention</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F832FEEF-4DBB-412B-8733-72214703E585</gtr:id><gtr:title>Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1a62a679e215f8109fef5aeee02e920"><gtr:id>e1a62a679e215f8109fef5aeee02e920</gtr:id><gtr:otherNames>Korolchuk VI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>1D5D840B85A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7DEDC63-72AA-418D-A2D1-9679D1C45589</gtr:id><gtr:title>Does bafilomycin A1 block the fusion of autophagosomes with lysosomes?</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_13471_11_18758232</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15BBC345-589C-4C8F-B13B-CCEC9E22008A</gtr:id><gtr:title>Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b957f5c686493ef530aa6c8d8777989"><gtr:id>1b957f5c686493ef530aa6c8d8777989</gtr:id><gtr:otherNames>Underwood BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>ni6hvADkbHU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>059F7E9A-0DCE-498E-83F6-FD297CE9D7FF</gtr:id><gtr:title>Loss of PINK1 function affects development and results in neurodegeneration in zebrafish.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7789910e30cfdb99414ad95dcfba7e1"><gtr:id>a7789910e30cfdb99414ad95dcfba7e1</gtr:id><gtr:otherNames>Anichtchik O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>4E86C3846D7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3767AC2-C514-41A0-9D7A-F64C4CFB5C57</gtr:id><gtr:title>1-O-Hexadecyl-2-O-methyl-3-O-(2'-acetamido-2'-deoxy-beta-D-glucopyranosyl)-sn-glycerol (Gln) induces cell death with more autophagosomes which is autophagy-independent.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7a0efed9f6c084db24a64fbd6e9e182"><gtr:id>d7a0efed9f6c084db24a64fbd6e9e182</gtr:id><gtr:otherNames>Jahreiss L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>585d4df1069ac7.14441278</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDAD15C2-4936-44D5-B308-66FF8312348A</gtr:id><gtr:title>Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89fbfd715cfa7a742a5e3d8de973a98c"><gtr:id>89fbfd715cfa7a742a5e3d8de973a98c</gtr:id><gtr:otherNames>Rodriguez-Cuenca S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>B75158EC5B2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>770EBF61-52B5-475B-B60A-CDAA672C8F87</gtr:id><gtr:title>Autophagy and aging.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fc15ca02a98b8ae96b659614dbdd5b8"><gtr:id>2fc15ca02a98b8ae96b659614dbdd5b8</gtr:id><gtr:otherNames>Rubinsztein DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>Xm4riphiWrm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D00A6C3-8199-4B14-81DD-CEFB32AAA164</gtr:id><gtr:title>Clearance of mutant aggregate-prone proteins by autophagy.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c684afaa55830b389d7cc1f42d26dc86"><gtr:id>c684afaa55830b389d7cc1f42d26dc86</gtr:id><gtr:otherNames>Ravikumar B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_13471_11_18425452</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>175B91A5-FA22-43C6-81ED-A47622B0D76D</gtr:id><gtr:title>alpha Pix enhances mutant huntingtin aggregation.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88315e0544e1941d9f68f0961277aedd"><gtr:id>88315e0544e1941d9f68f0961277aedd</gtr:id><gtr:otherNames>Eriguchi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>pm_13471_11_19969308</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74323E92-7ECB-4740-97B4-C345361E084A</gtr:id><gtr:title>Atg5 and Bcl-2 provide novel insights into the interplay between apoptosis and autophagy.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84299561b806b1664b65dc87dd000920"><gtr:id>84299561b806b1664b65dc87dd000920</gtr:id><gtr:otherNames>Luo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_13471_11_17431417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F767245C-420C-4BA8-9D00-6B9172878434</gtr:id><gtr:title>p21-activated kinase 1 promotes soluble mutant huntingtin self-interaction and enhances toxicity.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84299561b806b1664b65dc87dd000920"><gtr:id>84299561b806b1664b65dc87dd000920</gtr:id><gtr:otherNames>Luo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>C16B249C8B4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29A77452-5F87-42CB-84AD-41181A4B66E8</gtr:id><gtr:title>Decreased BDNF levels are a major contributor to the embryonic phenotype of huntingtin knockdown zebrafish.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cf1b08e2da62ba0d0bfba5e490d12a4"><gtr:id>1cf1b08e2da62ba0d0bfba5e490d12a4</gtr:id><gtr:otherNames>Diekmann H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>59827C92502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>404E8E34-0B00-4B80-9A89-0BCEC7986C13</gtr:id><gtr:title>Control of autophagy as a therapy for neurodegenerative disease.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c60322f366411eb591f1ac6def7ec32"><gtr:id>7c60322f366411eb591f1ac6def7ec32</gtr:id><gtr:otherNames>Harris H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>pm_13471_21_22187000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FD607E7-C763-448B-8CBD-57065F91EEA9</gtr:id><gtr:title>Small molecules enhance autophagy and reduce toxicity in Huntington's disease models.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caf3d032b5e39560b0be5e4330259686"><gtr:id>caf3d032b5e39560b0be5e4330259686</gtr:id><gtr:otherNames>Sarkar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>66E91515ED0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26F9A27D-939B-4449-AF0A-F7ABC1554BE4</gtr:id><gtr:title>Huntingtin promotes cell survival by preventing Pak2 cleavage.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84299561b806b1664b65dc87dd000920"><gtr:id>84299561b806b1664b65dc87dd000920</gtr:id><gtr:otherNames>Luo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>3482EC0B8DE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E1AD02A-F22D-44A0-8FD2-45DE455B1269</gtr:id><gtr:title>A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caf3d032b5e39560b0be5e4330259686"><gtr:id>caf3d032b5e39560b0be5e4330259686</gtr:id><gtr:otherNames>Sarkar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>177C434DDC8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD4532F5-B5B5-42B2-8E86-E46EBD5E9DDD</gtr:id><gtr:title>Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66ef18d27aaab3e2eb29829908cf1ed4"><gtr:id>66ef18d27aaab3e2eb29829908cf1ed4</gtr:id><gtr:otherNames>Williams A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>635EE0E90F2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0825DA1-8D61-4D7E-93DF-274055AD8CF8</gtr:id><gtr:title>The ubiquitin proteasome system in Huntington's disease and the spinocerebellar ataxias.</gtr:title><gtr:parentPublicationTitle>BMC biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19312f34fab8c4b94994c79b8e4c4db5"><gtr:id>19312f34fab8c4b94994c79b8e4c4db5</gtr:id><gtr:otherNames>Davies JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-2091</gtr:issn><gtr:outcomeId>C837C396D40</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C9369C4-0879-4D32-AAF5-7BC52662E225</gtr:id><gtr:title>Regulation of autophagy by lysosomal positioning.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1a62a679e215f8109fef5aeee02e920"><gtr:id>e1a62a679e215f8109fef5aeee02e920</gtr:id><gtr:otherNames>Korolchuk VI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_13471_21_21521941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>348CE80F-38F6-42DD-97AD-42F842591320</gtr:id><gtr:title>Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1a62a679e215f8109fef5aeee02e920"><gtr:id>e1a62a679e215f8109fef5aeee02e920</gtr:id><gtr:otherNames>Korolchuk VI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>qrtZvgKw11C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D14CB9E2-9862-4653-AB29-6AACC22C90E1</gtr:id><gtr:title>Autophagic substrate clearance requires activity of the syntaxin-5 SNARE complex.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdbb119d400cb9526a9e82f78c4f9e2b"><gtr:id>cdbb119d400cb9526a9e82f78c4f9e2b</gtr:id><gtr:otherNames>Renna M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>V66Wiw7MgHp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC2F233E-8F84-48C5-8CEB-0149738371A1</gtr:id><gtr:title>The itinerary of autophagosomes: from peripheral formation to kiss-and-run fusion with lysosomes.</gtr:title><gtr:parentPublicationTitle>Traffic (Copenhagen, Denmark)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7a0efed9f6c084db24a64fbd6e9e182"><gtr:id>d7a0efed9f6c084db24a64fbd6e9e182</gtr:id><gtr:otherNames>Jahreiss L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1398-9219</gtr:issn><gtr:outcomeId>6074C8DC905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80A54034-7984-4A64-A61A-E58F389B4DDD</gtr:id><gtr:title>Plasma membrane contributes to the formation of pre-autophagosomal structures.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c684afaa55830b389d7cc1f42d26dc86"><gtr:id>c684afaa55830b389d7cc1f42d26dc86</gtr:id><gtr:otherNames>Ravikumar B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>r1uJ7mba388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3EB646B-B8E7-4834-9B3B-16F3FA1B2893</gtr:id><gtr:title>Ubiquitin ligase Hrd1 enhances the degradation and suppresses the toxicity of polyglutamine-expanded huntingtin.</gtr:title><gtr:parentPublicationTitle>Experimental cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/976eaddf2bc9b147e2b76a86d7e294d5"><gtr:id>976eaddf2bc9b147e2b76a86d7e294d5</gtr:id><gtr:otherNames>Yang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-4827</gtr:issn><gtr:outcomeId>937976F17BD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D744EB7-F540-432A-B5B6-827163E704B2</gtr:id><gtr:title>a-Synuclein impairs macroautophagy: implications for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9c71f39db2e0093d7495f33a320eef4"><gtr:id>d9c71f39db2e0093d7495f33a320eef4</gtr:id><gtr:otherNames>Winslow AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>nqYCjF4Zmgp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0707B71E-0319-4B51-BFC6-9FBD886B9F10</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>D2D49E78C58</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E86C38C-DA53-4263-9EFD-EFD2B6744239</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f446e86d6836d8e6a5da49dfe563b87"><gtr:id>8f446e86d6836d8e6a5da49dfe563b87</gtr:id><gtr:otherNames>Galluzzi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>49BB0FF1ABD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>943CE8EB-3A85-499A-8B7B-1787E38536DE</gtr:id><gtr:title>Spinocerebellar ataxias caused by polyglutamine expansions: a review of therapeutic strategies.</gtr:title><gtr:parentPublicationTitle>Cerebellum (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b957f5c686493ef530aa6c8d8777989"><gtr:id>1b957f5c686493ef530aa6c8d8777989</gtr:id><gtr:otherNames>Underwood BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1473-4222</gtr:issn><gtr:outcomeId>pm_13471_11_18418676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>766F88F3-E184-42B0-BD27-F9CC7E49E997</gtr:id><gtr:title>The Hedgehog signalling pathway regulates autophagy.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5f2844786e918d6d020121b554ff860"><gtr:id>c5f2844786e918d6d020121b554ff860</gtr:id><gtr:otherNames>Jimenez-Sanchez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_13471_21_23149744</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B92650C9-EEA4-44AF-945F-283129DFED56</gtr:id><gtr:title>In search of an &amp;quot;autophagomometer&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fc15ca02a98b8ae96b659614dbdd5b8"><gtr:id>2fc15ca02a98b8ae96b659614dbdd5b8</gtr:id><gtr:otherNames>Rubinsztein DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_13471_11_19411822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4540240A-5C5C-4C2D-9472-DA0CACCC6859</gtr:id><gtr:title>Reducing Igf-1r levels leads to paradoxical and sexually dimorphic effects in HD mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae312a95b658688d9e502f838b047b75"><gtr:id>ae312a95b658688d9e502f838b047b75</gtr:id><gtr:otherNames>Corrochano S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>543ff162a67418.46976981</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>790715C9-2108-4C91-AD3C-1338F6851CA9</gtr:id><gtr:title>Autophagy and misfolded proteins in neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0377188d9a314a9771d6e6deb6606cc"><gtr:id>a0377188d9a314a9771d6e6deb6606cc</gtr:id><gtr:otherNames>Metcalf DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>pm_13471_21_21095248</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F093F7A-D77F-4DFD-89B0-5574D2AC0D76</gtr:id><gtr:title>Lysosomal storage diseases as disorders of autophagy.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c25168f7df76ce4881f3d4e719223182"><gtr:id>c25168f7df76ce4881f3d4e719223182</gtr:id><gtr:otherNames>Settembre C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_13471_11_18000397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F37217FC-1F26-4679-BB68-6719F85FE443</gtr:id><gtr:title>Apoptosis blocks Beclin 1-dependent autophagosome synthesis: an effect rescued by Bcl-xL.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84299561b806b1664b65dc87dd000920"><gtr:id>84299561b806b1664b65dc87dd000920</gtr:id><gtr:otherNames>Luo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>0212579F485</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE500672-7DEC-4C6C-BBF7-147AD26D720B</gtr:id><gtr:title>Autophagy: where next?</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fc15ca02a98b8ae96b659614dbdd5b8"><gtr:id>2fc15ca02a98b8ae96b659614dbdd5b8</gtr:id><gtr:otherNames>Rubinsztein DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>C3DCD775_7C3DCD775_7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67D62322-18A4-4ABD-BC90-4CAE6699717B</gtr:id><gtr:title>Autophagy in neurodegeneration and development.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9c71f39db2e0093d7495f33a320eef4"><gtr:id>d9c71f39db2e0093d7495f33a320eef4</gtr:id><gtr:otherNames>Winslow AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>C2FD9CA386B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1290D69A-4CE8-4427-8D6C-250584F45219</gtr:id><gtr:title>Autophagy modulation as a potential therapeutic target for diverse diseases.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Drug discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fc15ca02a98b8ae96b659614dbdd5b8"><gtr:id>2fc15ca02a98b8ae96b659614dbdd5b8</gtr:id><gtr:otherNames>Rubinsztein DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-1776</gtr:issn><gtr:outcomeId>pm_13471_21_22935804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>513C5CA8-4103-4251-AF05-A6EA140C7487</gtr:id><gtr:title>Autophagy induction rescues toxicity mediated by proteasome inhibition.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fc15ca02a98b8ae96b659614dbdd5b8"><gtr:id>2fc15ca02a98b8ae96b659614dbdd5b8</gtr:id><gtr:otherNames>Rubinsztein DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>pm_13471_11_17582326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85104450-BF5F-4689-9DF9-FF0D000CADEE</gtr:id><gtr:title>Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c684afaa55830b389d7cc1f42d26dc86"><gtr:id>c684afaa55830b389d7cc1f42d26dc86</gtr:id><gtr:otherNames>Ravikumar B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>4C733EDA8EE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16085414-1D57-42D7-B9B0-AC49E87A7F03</gtr:id><gtr:title>Mechanisms of autophagosome biogenesis.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fc15ca02a98b8ae96b659614dbdd5b8"><gtr:id>2fc15ca02a98b8ae96b659614dbdd5b8</gtr:id><gtr:otherNames>Rubinsztein DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>pm_13471_21_22240478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A72D415-5417-45CF-9F1A-A9EBCACA05CB</gtr:id><gtr:title>A novel link between autophagy and the ubiquitin-proteasome system.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1a62a679e215f8109fef5aeee02e920"><gtr:id>e1a62a679e215f8109fef5aeee02e920</gtr:id><gtr:otherNames>Korolchuk VI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>585d4df384a665.44650825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBEC2012-82CA-42A8-AC27-A51AF094282C</gtr:id><gtr:title>Cytoprotective roles for autophagy.</gtr:title><gtr:parentPublicationTitle>Current opinion in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d7cca8b160003943d3c80b09ea1a5d1"><gtr:id>6d7cca8b160003943d3c80b09ea1a5d1</gtr:id><gtr:otherNames>Moreau K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0955-0674</gtr:issn><gtr:outcomeId>DAEDE0325E5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C98C7A3-D2E7-4E95-AF8B-0DF860495794</gtr:id><gtr:title>Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdbb119d400cb9526a9e82f78c4f9e2b"><gtr:id>cdbb119d400cb9526a9e82f78c4f9e2b</gtr:id><gtr:otherNames>Renna M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>2584E18FE31</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AADE15A-427F-4E46-91A4-15297CF47C7E</gtr:id><gtr:title>Potential therapeutic applications of autophagy.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Drug discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fc15ca02a98b8ae96b659614dbdd5b8"><gtr:id>2fc15ca02a98b8ae96b659614dbdd5b8</gtr:id><gtr:otherNames>Rubinsztein DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1474-1776</gtr:issn><gtr:outcomeId>E25FB1E5877</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B1D7894-079C-4A76-8B4A-91756B810A59</gtr:id><gtr:title>Mammalian macroautophagy at a glance.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c684afaa55830b389d7cc1f42d26dc86"><gtr:id>c684afaa55830b389d7cc1f42d26dc86</gtr:id><gtr:otherNames>Ravikumar B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>B7FF870C74F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5092921-D018-4607-88B9-3DD544B4549B</gtr:id><gtr:title>IGF-1 receptor antagonism inhibits autophagy.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdbb119d400cb9526a9e82f78c4f9e2b"><gtr:id>cdbb119d400cb9526a9e82f78c4f9e2b</gtr:id><gtr:otherNames>Renna M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_13471_21_23804751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2763CA0-9FD0-414D-9D9C-46AA3BB648FC</gtr:id><gtr:title>Functional genomics approaches to neurodegenerative diseases.</gtr:title><gtr:parentPublicationTitle>Mammalian genome : official journal of the International Mammalian Genome Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fc15ca02a98b8ae96b659614dbdd5b8"><gtr:id>2fc15ca02a98b8ae96b659614dbdd5b8</gtr:id><gtr:otherNames>Rubinsztein DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0938-8990</gtr:issn><gtr:outcomeId>AA8373F288F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2467957-76DF-4057-9614-C62D9E7B3B37</gtr:id><gtr:title>Chemical modulators of autophagy as biological probes and potential therapeutics.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa5fd646b6c75048c7799638b384e965"><gtr:id>aa5fd646b6c75048c7799638b384e965</gtr:id><gtr:otherNames>Fleming A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>p5mB1QgeiAm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7823350-C711-4B72-9EFB-B6D836A85230</gtr:id><gtr:title>Protein misfolding disorders and macroautophagy.</gtr:title><gtr:parentPublicationTitle>Current opinion in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68d9bd81131c2ef85da0b3bb510c1948"><gtr:id>68d9bd81131c2ef85da0b3bb510c1948</gtr:id><gtr:otherNames>Menzies FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0955-0674</gtr:issn><gtr:outcomeId>mpChghjt7wu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B442DB95-FD01-46F1-AE67-BFFC04DBF0D7</gtr:id><gtr:title>Zebrafish as a model to understand autophagy and its role in neurological disease.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa5fd646b6c75048c7799638b384e965"><gtr:id>aa5fd646b6c75048c7799638b384e965</gtr:id><gtr:otherNames>Fleming A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>pm_13471_21_21256213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75430A63-8790-40AA-86A7-F2CC31C70E5F</gtr:id><gtr:title>Alpha-helix targeting reduces amyloid-beta peptide toxicity.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b5e243007b016cd917a432ada05fd7b"><gtr:id>5b5e243007b016cd917a432ada05fd7b</gtr:id><gtr:otherNames>Nerelius C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>doi_55faa1aa192c4575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD2A6B47-469C-4A39-AF81-59271C54A885</gtr:id><gtr:title>Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b2c4b9bfa444ff3f285bee9609de0e9"><gtr:id>5b2c4b9bfa444ff3f285bee9609de0e9</gtr:id><gtr:otherNames>van Ham TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>T9jaQBmRzVS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4195DF80-DCC2-4F7A-91A6-0F727218537B</gtr:id><gtr:title>Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68d9bd81131c2ef85da0b3bb510c1948"><gtr:id>68d9bd81131c2ef85da0b3bb510c1948</gtr:id><gtr:otherNames>Menzies FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>F329A639351</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8267858-7E1C-44A0-B492-70A74D9BC7FF</gtr:id><gtr:title>Small molecule enhancers of autophagy for neurodegenerative diseases.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caf3d032b5e39560b0be5e4330259686"><gtr:id>caf3d032b5e39560b0be5e4330259686</gtr:id><gtr:otherNames>Sarkar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>4D94BB8F395</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30688E99-579F-4249-8170-41B7F34CDE6B</gtr:id><gtr:title>Methodological considerations for assessing autophagy modulators: a study with calcium phosphate precipitates.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caf3d032b5e39560b0be5e4330259686"><gtr:id>caf3d032b5e39560b0be5e4330259686</gtr:id><gtr:otherNames>Sarkar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>585d4df7e31664.44627144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35D22134-767B-499A-805E-5712E528AE1B</gtr:id><gtr:title>Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a340fbb42265c9ec6bc733e0a04c590"><gtr:id>2a340fbb42265c9ec6bc733e0a04c590</gtr:id><gtr:otherNames>Zheng S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>4C66F8B1A05</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F2CBBAA-3DDE-4217-B519-0AE818A9936B</gtr:id><gtr:title>Regulation of mammalian autophagy in physiology and pathophysiology.</gtr:title><gtr:parentPublicationTitle>Physiological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c684afaa55830b389d7cc1f42d26dc86"><gtr:id>c684afaa55830b389d7cc1f42d26dc86</gtr:id><gtr:otherNames>Ravikumar B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0031-9333</gtr:issn><gtr:outcomeId>K5jZc2Qg9kZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D8E3777-3BEB-4B99-93A8-DD0DA84AA0A1</gtr:id><gtr:title>Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/592ee7649769732bf204fc9e96a82554"><gtr:id>592ee7649769732bf204fc9e96a82554</gtr:id><gtr:otherNames>Floto RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_13471_11_17786022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18AAFC6F-597E-4BEC-816F-822D93FF0C45</gtr:id><gtr:title>Huntington's disease: degradation of mutant huntingtin by autophagy.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caf3d032b5e39560b0be5e4330259686"><gtr:id>caf3d032b5e39560b0be5e4330259686</gtr:id><gtr:otherNames>Sarkar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>6F020B40539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF5F3EFA-E662-491C-A74D-34D2548CA53E</gtr:id><gtr:title>TFEB links autophagy to lysosomal biogenesis.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c25168f7df76ce4881f3d4e719223182"><gtr:id>c25168f7df76ce4881f3d4e719223182</gtr:id><gtr:otherNames>Settembre C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pYCV5xgrehe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>883E0541-D1D6-4CC3-ADD2-BCA96A2F40DE</gtr:id><gtr:title>The Parkinson disease protein a-synuclein inhibits autophagy.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9c71f39db2e0093d7495f33a320eef4"><gtr:id>d9c71f39db2e0093d7495f33a320eef4</gtr:id><gtr:otherNames>Winslow AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_13471_21_21157184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CAD19DF-6FEF-420F-9511-4C6AE710FDD0</gtr:id><gtr:title>Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bc21cf831165d5824421ae28c0c59b4"><gtr:id>4bc21cf831165d5824421ae28c0c59b4</gtr:id><gtr:otherNames>Futter M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>47D94B62995</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77D324F4-5C46-4CC1-B235-4200C9187888</gtr:id><gtr:title>a-Synuclein levels affect autophagosome numbers in vivo and modulate Huntington disease pathology.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae312a95b658688d9e502f838b047b75"><gtr:id>ae312a95b658688d9e502f838b047b75</gtr:id><gtr:otherNames>Corrochano S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_13471_21_22361581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB3FFB1B-EE09-4F1A-A8D4-EF561B3DEA25</gtr:id><gtr:title>a-Synuclein levels modulate Huntington's disease in mice.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae312a95b658688d9e502f838b047b75"><gtr:id>ae312a95b658688d9e502f838b047b75</gtr:id><gtr:otherNames>Corrochano S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_13471_21_22010050</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57055AFF-6BFB-47EF-B8FC-6AFC77F59F39</gtr:id><gtr:title>Autophagy, a guardian against neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Seminars in cell &amp; developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b60f91e9e1b2a65d4d8947bb9234b86b"><gtr:id>b60f91e9e1b2a65d4d8947bb9234b86b</gtr:id><gtr:otherNames>Garc?a-Arencibia M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1084-9521</gtr:issn><gtr:outcomeId>05F4F827_E05F4F827_E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F5EACC9-A4EA-47A0-8ABE-FC637A7481D5</gtr:id><gtr:title>Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68d9bd81131c2ef85da0b3bb510c1948"><gtr:id>68d9bd81131c2ef85da0b3bb510c1948</gtr:id><gtr:otherNames>Menzies FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>QiBaTqZAVtw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02158546-8C62-4B19-8D5B-7D15D10BAA73</gtr:id><gtr:title>Complex inhibitory effects of nitric oxide on autophagy.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caf3d032b5e39560b0be5e4330259686"><gtr:id>caf3d032b5e39560b0be5e4330259686</gtr:id><gtr:otherNames>Sarkar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>kBhEqM1zu3Z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB90D945-5B36-4DF1-85C3-062CD6FC57D5</gtr:id><gtr:title>Autophagic clearance of aggregate-prone proteins associated with neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caf3d032b5e39560b0be5e4330259686"><gtr:id>caf3d032b5e39560b0be5e4330259686</gtr:id><gtr:otherNames>Sarkar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>F2B5C16CC71</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDBC7FC9-1B0F-4E9C-8FB2-2DCBA5BD93D2</gtr:id><gtr:title>Huntington's disease: from pathology and genetics to potential therapies.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55adda9ac85e08081c4b098fe11665a4"><gtr:id>55adda9ac85e08081c4b098fe11665a4</gtr:id><gtr:otherNames>Imarisio S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>974367A9C2E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA62782B-00C7-4DAC-A27B-2FD28C672BAE</gtr:id><gtr:title>Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caf3d032b5e39560b0be5e4330259686"><gtr:id>caf3d032b5e39560b0be5e4330259686</gtr:id><gtr:otherNames>Sarkar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>824F41AF397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F9869A5-1644-4C24-87E1-1B2639227D93</gtr:id><gtr:title>Autophagy and polyglutamine diseases.</gtr:title><gtr:parentPublicationTitle>Progress in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5f2844786e918d6d020121b554ff860"><gtr:id>c5f2844786e918d6d020121b554ff860</gtr:id><gtr:otherNames>Jimenez-Sanchez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0301-0082</gtr:issn><gtr:outcomeId>c65vwwxEt2R</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1D63843-4999-47BF-BF57-6C5568A0C5E4</gtr:id><gtr:title>Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caf3d032b5e39560b0be5e4330259686"><gtr:id>caf3d032b5e39560b0be5e4330259686</gtr:id><gtr:otherNames>Sarkar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>3DF254A3799</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>175A0C7E-56E8-4AA7-9B2F-09E971BDB35E</gtr:id><gtr:title>Autophagosome precursor maturation requires homotypic fusion.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d7cca8b160003943d3c80b09ea1a5d1"><gtr:id>6d7cca8b160003943d3c80b09ea1a5d1</gtr:id><gtr:otherNames>Moreau K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>kvzamZkQEri</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB0BC521-0917-4630-B6B2-34904EA3587E</gtr:id><gtr:title>A comprehensive glossary of autophagy-related molecules and processes.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>HZFAkwDgmhm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6002DF0D-3114-4543-8E84-242056D6C8AC</gtr:id><gtr:title>Laforin, the most common protein mutated in Lafora disease, regulates autophagy.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15e3e4e38f7a1ac35eec0bad830b2514"><gtr:id>15e3e4e38f7a1ac35eec0bad830b2514</gtr:id><gtr:otherNames>Aguado C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>rmcBixLNy6e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4DF21E9-29A5-4278-B471-AF1B33334D03</gtr:id><gtr:title>Lysosomal positioning coordinates cellular nutrient responses.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1a62a679e215f8109fef5aeee02e920"><gtr:id>e1a62a679e215f8109fef5aeee02e920</gtr:id><gtr:otherNames>Korolchuk VI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>VnCKaH5oFCe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72A9BEB1-3D3A-4030-83AD-CFCC9C257B43</gtr:id><gtr:title>A block of autophagy in lysosomal storage disorders.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c25168f7df76ce4881f3d4e719223182"><gtr:id>c25168f7df76ce4881f3d4e719223182</gtr:id><gtr:otherNames>Settembre C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_13471_11_17913701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>307D6A38-3ACF-49A7-B085-361EB5255660</gtr:id><gtr:title>Broadening the therapeutic scope for rapamycin treatment.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68d9bd81131c2ef85da0b3bb510c1948"><gtr:id>68d9bd81131c2ef85da0b3bb510c1948</gtr:id><gtr:otherNames>Menzies FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_13471_21_20081360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FB5FEC9-4298-4765-9D2C-6F171F0508FA</gtr:id><gtr:title>Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ab26a795c38d8b7eb455b565fab3fef"><gtr:id>3ab26a795c38d8b7eb455b565fab3fef</gtr:id><gtr:otherNames>Rose C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>26078749204</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600194</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>